These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8420422)

  • 1. Surfactant and the adult respiratory distress syndrome.
    Lewis JF; Jobe AH
    Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome.
    Holm BA; Matalon S
    Anesth Analg; 1989 Dec; 69(6):805-18. PubMed ID: 2686493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of surfactant therapy during ALI/ARDS.
    Lewis JF; Veldhuizen RA
    Semin Respir Crit Care Med; 2006 Aug; 27(4):377-88. PubMed ID: 16909371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exogenous surfactant in the treatment of acute lung injury.
    Lewis JF; Veldhuizen R
    Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
    Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
    Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).
    Hartog A; Gommers D; Lachmann B
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant replacement therapy for adult respiratory distress syndrome in children.
    Evans DA; Wilmott RW; Whitsett JA
    Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
    Robertson B
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):64-9. PubMed ID: 9632910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical behavior of lung surfactant: implications for respiratory physiology and pathophysiology.
    Notter RH
    Semin Perinatol; 1988 Jul; 12(3):180-212. PubMed ID: 3041603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
    Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
    Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing efficacy of exogenous surfactant in acute lung injury.
    Lewis JF; Veldhuizen RA
    Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of exogenous surfactant in acute lung injury.
    Lewis JF; Brackenbury A
    Crit Care Med; 2003 Apr; 31(4 Suppl):S324-8. PubMed ID: 12682460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition and function of pulmonary surfactant in adult respiratory distress syndrome.
    Hallman M; Maasilta P; Sipilä I; Tahvanainen J
    Eur Respir J Suppl; 1989 Mar; 3():104s-108s. PubMed ID: 2662993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of acute respiratory distress syndrome: role of surfactant changes and mechanical ventilation.
    Verbrugge SJ; Sorm V; Lachmann B
    J Physiol Pharmacol; 1997 Dec; 48(4):537-57. PubMed ID: 9444607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
    Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspectives in mechanical ventilation in ARDS].
    Max M; Kaisers U; Rossaint R
    Schweiz Med Wochenschr; 1997 Jun; 127(24):1030-8. PubMed ID: 9289830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the endogenous surfactant system in septic adult rats.
    Malloy J; McCaig L; Veldhuizen R; Yao LJ; Joseph M; Whitsett J; Lewis J
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):617-23. PubMed ID: 9279248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.